Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Exploring colorectal cancer in Hispanic/Latino populations through multi-omics analysis of MYC gene and WNT signalling pathway alteration

Dr Enrique Velazquez Villarreal - CIty of Hope, Duarte, USA
Exploring colorectal cancer in Hispanic/Latino populations through multi-omics analysis of MYC gene and WNT signalling pathway alteration ( Dr Enrique Velazquez Villarreal - CIty of Hope, Duarte, USA )
7 May 2025

Higher visceral fat linked to reduced overall survival in older adults with newly diagnosed gastrointestinal malignancies

Dr Supriya Maheshwari - University of Alabama, Tuscaloosa, USA
Higher visceral fat linked to reduced overall survival in older adults with newly diagnosed gastrointestinal malignancies ( Dr Supriya Maheshwari - University of Alabama, Tuscaloosa, USA )
10 Mar 2025

ctDNA evaluation may play a prognostic role in stage III colon cancer treated with celecoxib

Dr Jonathan Andrew Nowak - Dana-Farber Cancer Institute, Boston, USA
ctDNA evaluation may play a prognostic role in stage III colon cancer treated with celecoxib ( Dr Jonathan Andrew Nowak - Dana-Farber Cancer Institute, Boston, USA )
26 Feb 2025

Addition of trastuzumab to chemo does not provide significant survival benefit in HER-2 positive stomach cancer

Dr Anna Dorothea Wagner - Lausanne University Hospital, Lausanne, Switzerland
Addition of trastuzumab to chemo does not provide significant survival benefit in HER-2 positive stomach cancer ( Dr Anna Dorothea Wagner - Lausanne University Hospital, Lausanne, Switzerland )
21 Feb 2025

SIOG 2024: Updates in radiation oncology

Dr Lucinda Morris - Crown Princess Mary Cancer Centre, Westmead, Australia
SIOG 2024: Updates in radiation oncology ( Dr Lucinda Morris - Crown Princess Mary Cancer Centre, Westmead, Australia )
19 Feb 2025

SIOG 2024: Updates in medical oncology

Dr Capucine Baldini - Gustave Roussy, Villejuif, France
SIOG 2024: Updates in medical oncology ( Dr Capucine Baldini - Gustave Roussy, Villejuif, France )
19 Feb 2025

Low-dose aspirin can reduce recurrence rates in colorectal cancer patients with PI3K pathway alterations

Prof Anna Martling - Karolinska Institutet, Stockholm, Sweden
Low-dose aspirin can reduce recurrence rates in colorectal cancer patients with PI3K pathway alterations ( Prof Anna Martling - Karolinska Institutet, Stockholm, Sweden )
14 Feb 2025

Nivolumab plus ipilimumab shows superior efficacy in metastatic colorectal compared to nivolumab monotherapy

Dr Thierry Andre - Sorbonne Université and Saint Antoine Hospital, Paris, France
Nivolumab plus ipilimumab shows superior efficacy in metastatic colorectal compared to nivolumab monotherapy ( Dr Thierry Andre - Sorbonne Université and Saint Antoine Hospital, Paris, France )
13 Feb 2025

Assessment and management of toxic effects of cancer therapy in elderly patients in Tunisia

Dr Houda Belfekih - Mohamed Taher Maamouri Hospital, Nabeul, Tunisia
Assessment and management of toxic effects of cancer therapy in elderly patients in Tunisia ( Dr Houda Belfekih - Mohamed Taher Maamouri Hospital, Nabeul, Tunisia )
13 Feb 2025

Robotic surgery for older patients with colorectal cancer shows positive outcomes

Prof Lore Decoster - University Hospital Brussels, Brussels, Belgium
Robotic surgery for older patients with colorectal cancer shows positive outcomes ( Prof Lore Decoster - University Hospital Brussels, Brussels, Belgium )
13 Feb 2025

Blood-based test may provide a convenient and effective option for CRC screening in the average-risk U.S. population

Dr Aasma Shaukat - NYU Grossman School of Medicine, New York, USA
Blood-based test may provide a convenient and effective option for CRC screening in the average-risk U.S. population ( Dr Aasma Shaukat - NYU Grossman School of Medicine, New York, USA )
29 Jan 2025

Everolimus plus lanreotide might be a new standard treatment in the first-line setting for grade 1/2 GEP-NETs

Dr Susumu Hijioka - National Cancer Center Hospital, Chuo City, Japan
Everolimus plus lanreotide might be a new standard treatment in the first-line setting for grade 1/2 GEP-NETs ( Dr Susumu Hijioka - National Cancer Center Hospital, Chuo City, Japan )
29 Jan 2025